Settings8H · net · $10k
LanguageThe language of the site
FundingPeriod funding rates are shown in
UnitsPercent or basis points
CostsCount taker fees and slippage in Net
SizePosition per leg used for Net and slippage
ExchangesWhich exchanges to include everywhere
My profile →
My profile
Backtest 30d
LegExchangePriceFund. /8hEach paymentNext inOIVol 24hLev
LONG138.76+0.0048pay 0.0006% / 1h2m 33s$359K$172K20xLong Popdex
SHORT137.83+0.0033get 0.0004% / 1h2m 33s$27K$101K10xShort Injective
Price gap−0.670%46s
Funding gap−0.0015% /8h

Both sides work against this direction now: funding costs $0 a day on $10k and the gap is 0.822% under its 7d average. Swap the legs.

The two prices were read 46 s apart: part of this gap may be the market moving.

If you open now and hold

on $10k a leg · figures of the last 7D, not a forecast
Funding−$5−0.0015% /8h now · paid −0.050% over the last 6 days (all we have)
Price—spread −0.670%46s now · prices read too far apart to compare
Costsdoesn’t fit$10k a leg is deeper than the books hold
Result, before costs—no pointsneeds both prices read together

Funding history

you earnyou payavg
RANGE STATS · 7D
Average /8h—
Highest—
Lowest—
Paid you—

Short leg rate minus long leg rate, per 8h. Above zero: the pair pays you.

Price spread between the two exchanges

Injective price against Popdexnow
RANGE STATS · 7D
Now−0.670%
Average—
Range—
Wider than now—

Where the spread has been, last 7D

share of time at each level

Funding on every exchange

/8h

ORCL on 29 exchanges

lowest funding first

Before you open

2 ok · 3 to watch
  • Problem: Doesn’t fit the books—
    $10k a leg is deeper than Injective’s order book right now.
  • Note: Margin at max leverage$500 + $1,000
    Popdex 20x, Injective 10x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
  • OK: Same payment interval1h / 1h
    Both legs pay at the same time.
    Next 24h at the current rates, on $10k a leg: −$0.44Long Popdex: 24 payments, −$1.44; short Injective: 24 payments, +$1.00.
  • Watch: Prices read 46 s apart−0.670% vs +0.151%
    Part of this gap may be the market moving.
  • Watch: Short leg is thinner$27K vs $359K OI
    Injective sets your exit cost. Check its book before closing.
  • Note: No points program—
    Neither exchange runs points right now.
  • OK: No KYC on either legPopdex No · Injective No
    Both exchanges let you trade without ID.

Profit calculator

both legs, in and out
Position, each leg
Hold for
Orders
Price spread
Funding rate
Funding earned−0.0028%/8h × 21 periods−$5.91
Price spreadprices read too far apart to compare—
Slippage, 4 ordersdoesn’t fit the book at $10k—
Fee Popdex bp × 2 orders−$6.40
Fee Injective bp × 2 orders−$0.02
Net · 7 days · $10k—
doesn’t fit the books at $10kprice spread not counted: prices read too far apart
Costs to cover—Break-even—
Slippage: Popdex: live order book, 15 min ago; Injective: live order book, 46 min ago

Cost to enter

taker + slippage from mid, one side
BUY · LONGPopdex1.086.8 bp−$738.9 bp−$389doesn’t fitdoesn’t fit
SELL · SHORTInjective38.88doesn’t fitdoesn’t fitdoesn’t fitdoesn’t fit

Closing costs about the same again.

Alert

ORCL news

posts that mention ORCL or Oracle, from every exchangeSearch all news →
09-29 19:30Vest MarketsOtherTrade $ORCL volatility with a Vest Capital funded account and access up to $25k in trading capital at: @VestExchange on X ↗
09-29 19:30Vest MarketsOtherHeading into the close, $ORCL is up around 4.2% with the launch of Fusion Claw, which adds 25 agentic applications. The company also introduced a native NetApp storage service on its cloud, with a full rollout planned within 12 months. The move puts the shares on pace to snap a four-day losing streak that had taken them about 11% lower. @VestExchange on X ↗
09-28 17:30Vest MarketsOtherOracle's AI financing model is drawing fresh skepticism, with $ORCL down around 2.7% on the session. S&P lowered the credit rating to BBB-, the shares drew a Sell rating this morning, and five-year default swaps reached a record 227 basis points last week. The $18B of debt tied to Project Jupiter is quoted near 89 cents on the dollar, with about half of Oracle's $664B backlog tied to OpenAI. @VestExchange on X ↗
09-27 09:40KalshiOtherJUST IN: Oracle reportedly gave Larry Ellison and co-CEOs nearly $1 billion in stock options that "had no value" by fiscal year-end @Kalshi on X ↗
09-25 03:59KalshiOtherJUST IN: Oracle's "investment grade" bond closed at 8.10%, in line with B3/B- junk @Kalshi on X ↗
09-24 13:30Vest MarketsOther$ORCL is down around 5.4% into the open, with a reported force majeure notice to its New Mexico data center developer. The notice goes to developer Blue Owl on Project Jupiter, seeking to defer payments if the 1,400-acre campus behind Oracle's OpenAI capacity deal slips past 2028. Trade $ORCL volatility with a Vest Capital funded account and access up to $25k in trading capital. @VestExchange on X ↗